MedPath

RIVA-ZIDE 50/25MG TABLETS

RIVA-ZIDE 50/25MG TABLETS

Discontinued
DIN Number

02240846

Drug Class

Human

Market Date

Nov 5, 1999

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240846
AIG Number0201052001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03EA01 HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 25 MG
Monograph: HYDROCHLOROTHIAZIDE
TRIAMTERENEActive
Strength: 50 MG
Monograph: TRIAMTERENE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.